Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation
S Kamel, Linda W. Horton, Loïc Ysebaert, M Levade, Kate Burbury, Seng‐Lai Tan, M. Cole‐Sinclair, John Reynolds, Robin Filshie, S. Schischka, Amit Khot, Shahneen Sandhu, Michael J. Keating, Harshal Nandurkar, Constantine S. Tam (2014). Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation. , 29(4), DOI: https://doi.org/10.1038/leu.2014.247.
Article301 days ago<i>CD274</i> structural variants for guiding treatment with PD-1 blockade in a patient with relapsed/refractory chronic active EBV transformed to NK lymphoma
S. Robinson, Song Wu, Stephen Lade, Constantine S. Tam, Eric Wong, Amit Khot, P. Blombery (2024). <i>CD274</i> structural variants for guiding treatment with PD-1 blockade in a patient with relapsed/refractory chronic active EBV transformed to NK lymphoma. , DOI: https://doi.org/10.1080/10428194.2024.2404954.
Article301 days agoAllogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in <i>TP53</i> -mutated disease
Thomas E. Lew, Edward R. Scheffer Cliff, Michael Dickinson, Constantine S. Tam, John F. Seymour, Piers Blombery, Ashish Bajel, David Ritchie, Amit Khot (2023). Allogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in <i>TP53</i> -mutated disease. , 64(11), DOI: https://doi.org/10.1080/10428194.2023.2241095.
Article301 days agoTreatment approaches for patients with TP53-mutated mantle cell lymphoma
Thomas E. Lew, Adrian Minson, Michael Dickinson, Sasanka M. Handunnetti, Piers Blombery, Amit Khot, Mary Ann Anderson, David Ritchie, Constantine S. Tam, John F. Seymour (2023). Treatment approaches for patients with TP53-mutated mantle cell lymphoma. , 10(2), DOI: https://doi.org/10.1016/s2352-3026(22)00355-6.
Article301 days agoCAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study
Adrian Minson, Nada Hamad, Chan Y. Cheah, Constantine S. Tam, Piers Blombery, David Westerman, David Ritchie, Huw Morgan, Nicholas Holzwart, Stephen Lade, Mary Ann Anderson, Amit Khot, John F. Seymour, Molly Robertson, Imogen Caldwell, Georgina L. Ryland, Javad Saghebi, Zahra Sabahi, Jing Xie, Rachel Koldej, Michael Dickinson (2023). CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study. , 143(8), DOI: https://doi.org/10.1182/blood.2023021306.
Article301 days ago